NovoCure surges on Q2 results
NovoCure (Nasdaq: NVCR), a developer of cancer treatments by focusing electric fields on the growth, reported $184 million revenue ...
Thursday, July 23, 2026
Tag: Novocure
Approval for pancreatic cancer treatment boosts Novocure
Novocure (Nasdaq: NVCR), developer of a technology for treating cancer by means of electric fields, announced today that the ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.